A critical analysis of current in vitro and in vivo angiogenesis assays

CA Staton, MWR Reed… - International journal of …, 2009 - Wiley Online Library
The study of angiogenesis has grown exponentially over the past 40 years with the
recognition that angiogenesis is essential for numerous pathologies and, more recently, with …

Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 1

SM Sagar, D Yance, RK Wong - Current Oncology, 2006 - mdpi.com
An integrative approach for managing a patient with cancer should target the multiple
biochemical and physiologic pathways that support tumour development and minimize …

50 years of preclinical anticancer drug screening: empirical to target-driven approaches

M Suggitt, MC Bibby - Clinical Cancer Research, 2005 - AACR
The number of anticancer agents that fail in the clinic far outweighs those considered
effective, suggesting that the selection procedure for progression of molecules into the clinic …

Targeting angiogenesis with integrative cancer therapies

DR Yance Jr, SM Sagar - Integrative cancer therapies, 2006 - journals.sagepub.com
An integrative approach for managing a patient with cancer should target the multiple
biochemical and physiological pathways that support tumor development while minimizing …

Biological aspects in controlling angiogenesis: current progress

M Akbarian, LE Bertassoni, L Tayebi - Cellular and Molecular Life …, 2022 - Springer
All living beings continue their life by receiving energy and by excreting waste products. In
animals, the arteries are the pathways of these transfers to the cells. Angiogenesis, the …

Analysis of the role of chemokines in angiogenesis

G Bernardini, D Ribatti, G Spinetti, L Morbidelli… - Journal of …, 2003 - Elsevier
Chemokines, a large family of inflammatory cytokines, have been shown to play a critical
role in the regulation of angiogenesis during several pathophysiologic processes, such as …

Tumor angiogenesis as a target for dietary cancer prevention

WW Li, VW Li, M Hutnik, AS Chiou - Journal of oncology, 2012 - Wiley Online Library
Between 2000 and 2050, the number of new cancer patients diagnosed annually is
expected to double, with an accompanying increase in treatment costs of more than $80 …

Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation

SG Cho, Z Yi, X Pang, T Yi, Y Wang, J Luo, Z Wu, D Li… - Cancer research, 2009 - AACR
Abstract Kisspeptin-10 (Kp-10), a decapeptide derived from the primary translation product
of KISS1 gene, has been reported previously to be a key hormone for puberty and an …

Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3

SR Boreddy, RP Sahu, SK Srivastava - PloS one, 2011 - journals.plos.org
Our previous studies have shown that benzyl isothiocyanate (BITC) suppresses pancreatic
tumor growth by inhibiting STAT-3; however, the exact mechanism of tumor growth …

Modeling human tumor angiogenesis in a three-dimensional culture system

G Seano, G Chiaverina, PA Gagliardi… - Blood, The Journal …, 2013 - ashpublications.org
The intrinsic complexity of the process of vessel formation limits the efficacy of cellular
assays for elucidation of its molecular and pharmacologic mechanisms. We developed an …